We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
31 hedge funds and large institutions have $108M invested in scPharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
10% more capital invested
Capital invested by funds: $97.9M → $108M (+$10M)
9% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 11
0.74% more ownership
Funds ownership: 58.58% → 59.32% (+0.74%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
18% less funds holding
Funds holding: 38 → 31 (-7)
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Holders
31
Holders Change
-7
Holders Change %
-18.42%
% of All Funds
0.54%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
12
Reduced
11
Closed
9
Calls
$21K
Puts
–
Net Calls
+$21K
Net Calls Change
+$3K
Top Buyers
Top Sellers
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$1.19M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.16M |
| 3 |
Goldman Sachs
New York
|
-$704K |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$238K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$228K |
